325 related articles for article (PubMed ID: 8203084)
1. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders.
Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E
Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084
[TBL] [Abstract][Full Text] [Related]
2. Comparison of image analysis and flow cytometric measurements of DNA content of canine transitional cell carcinomas.
Clemo FA; Crabtree WN; Walker E; DeNicola DB
Anal Quant Cytol Histol; 1993 Dec; 15(6):418-26. PubMed ID: 8297432
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
Sasaki K; Hamano K; Kinjo M; Hara S
Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity of canine transitional cell carcinoma of the urinary bladder with monoclonal antibodies to tumor-associated glycoprotein 72.
Clemo FA; DeNicola DB; Carlton WW; Walker E; Morrison WB
Vet Pathol; 1995 Mar; 32(2):155-61. PubMed ID: 7771056
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
[TBL] [Abstract][Full Text] [Related]
6. DNA-Flow cytometric analysis of bladder TCC using paraffin-embedded tissues.
Wu L; Lochhead A; Yang J; Ow KT; Russell PJ
Urol Int; 1998 Aug; 60(4):208-15. PubMed ID: 9701732
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
Miao T; Wang Z; Sang N; Xiong R; Cao S
Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
[TBL] [Abstract][Full Text] [Related]
8. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
Toyota K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
[TBL] [Abstract][Full Text] [Related]
9. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.
Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG
J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of DNA ploidy of transitional cell carcinoma of urinary bladder using flow cytometry.
Pan ST; Chan LP; Yu KC; Chang MC; Ho WL
Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Jan; 10(1):22-7. PubMed ID: 8176764
[TBL] [Abstract][Full Text] [Related]
11. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors.
Ayl RD; Couto CG; Hammer AS; Weisbrode S; Ericson JG; Mathes L
Vet Pathol; 1992 Sep; 29(5):386-90. PubMed ID: 1413405
[TBL] [Abstract][Full Text] [Related]
12. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
Wang Z
Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
[TBL] [Abstract][Full Text] [Related]
13. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
[TBL] [Abstract][Full Text] [Related]
15. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy of bladder cancer using bladder biopsy supernate specimens.
Loughman NT; Lin BP; Dent OF; Newland RC
Anal Quant Cytol Histol; 2003 Jun; 25(3):146-58. PubMed ID: 12882086
[TBL] [Abstract][Full Text] [Related]
17. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder.
Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB
J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis.
Lee SE; Park MS
Eur Urol; 1996; 29(2):193-8. PubMed ID: 8647146
[TBL] [Abstract][Full Text] [Related]
19. Cytomorphometric and flow cytometric analysis of bladder transitional cell carcinoma using acridine orange fluorochrome: correlation with histopathology and clinical behavior.
Yu DS; Hsu CM; Chang SY; Ma CP
J Formos Med Assoc; 1992 Feb; 91(2):152-8. PubMed ID: 1364210
[TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometric study of the hyperplastic and neoplastic canine prostate.
Madewell BR; Deitch AD; Higgins RJ; Marks SL; deVere White RW
Prostate; 1991; 18(2):173-9. PubMed ID: 1706513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
